Europe Electronic Clinical Outcome Assessment (eCOA) Market - Industry Trends and Forecast to 2033

TABLE OF CONTENTS

1 INTRODUCTION 43

• 1.1 OBJECTIVES OF THE STUDY 43
• 1.2 MARKET DEFINITION 43
• 1.3 OVERVIEW OF THE EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 43
• 1.4 LIMITATIONS 44
• 1.5 MARKETS COVERED 45

2 MARKET SEGMENTATION 47

• 2.1 MARKETS COVERED 47
• 2.2 GEOGRAPHICAL SCOPE 48
• 2.3 YEARS CONSIDERED FOR THE STUDY 49
• 2.4 CURRENCY AND PRICING 49
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL 50
• 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53
• 2.7 DBMR MARKET POSITION GRID 54
• 2.8 VENDOR SHARE ANALYSIS 56
• 2.9 MULTIVARIATE MODELLING 57
• 2.10 TYPE TIMELINE CURVE 58
• 2.11 MARKET APPLICATION COVERAGE GRID 59
• 2.12 SECONDARY SOURCES 60
• 2.13 ASSUMPTIONS 60

3 EXECUTIVE SUMMARY 61

4 PREMIUM INSIGHTS 63

• 4.1 PESTEL ANALYSIS 64
• 4.2 PORTER'S FIVE FORCES ANALYSIS 65

5 REGULATORY FRAMEWORK 66

6 MARKET OVERVIEW 68

• 6.1 DRIVERS 70
  • 6.1.1 GROWING ACCEPTANCE OF ECOA AMONG CLINICAL RESEARCH PROFESSIONALS 70
  • 6.1.2 PARADIGM SHIFT TOWARDS ELECTRONIC DATA CAPTURING FROM PAPER-BASED PROCEDURES 71
  • 6.1.3 GOVERNMENT INITIATIVES ABOUT THE ADOPTION OF ECLINICAL PLATFORMS 72
• 6.2 RESTRAINTS 73
  • 6.2.1 IMPLEMENTATION OF 'BRING YOUR OWN DEVICE' (BYOD) TECHNOLOGY IN CLINICAL TRIALS 73
  • 6.2.2 LACK OF PROPER HEALTHCARE IT INFRASTRUCTURE IN DEVELOPING COUNTRIES 74
• 6.3 OPPORTUNITIES 74
  • 6.3.1 GROWING ADOPTION OF CLOUD-BASED SERVICES 74
  • 6.3.2 RISING NUMBER OF RESEARCH STUDIES FOCUSING ON CLINICAL OUTCOME ASSESSMENTS 75
• 6.4 CHALLENGES 76
  • 6.4.1 DIFFICULTIES ASSOCIATED WITH TRAINING OF RESPONDENTS TO FILL ELECTRONIC QUESTIONNAIRES 76
  • 6.4.2 STREAMLINING OF ECOA SERVICES 76

7 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE 78

• 7.1 OVERVIEW 79
• 7.2 CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) 80
• 7.3 PATIENT REPORTED OUTCOME ASSESSMENT (PRO) 81
• 7.4 OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO) 81
• 7.5 PERFORMANCE OUTCOME ASSESSMENT (PERFO) 82

8 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY 83

• 8.1 OVERVIEW 84
• 8.2 SITE-BASED SOLUTIONS 85
• 8.3 WEB SOLUTIONS 86
• 8.4 HANDHELD 86
  • 8.4.1 BRING-YOUR-OWN-DEVICE (BYOD) 87
  • 8.4.2 PROVISIONED DEVICES 87

9 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER 88

• 9.1 OVERVIEW 89
• 9.2 CONTRACT RESEARCH ORGANIZATIONS (CROS) 90
  • 9.2.1 SITE-BASED SOLUTIONS 91
  • 9.2.2 WEB SOLUTIONS 91
  • 9.2.3 HANDHELD 91
• 9.3 PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS 91
  • 9.3.1 SITE-BASED SOLUTIONS 92
  • 9.3.2 WEB SOLUTIONS 92
  • 9.3.3 HANDHELD 92
• 9.4 MEDICAL DEVICE COMPANIES 92
  • 9.4.1 SITE-BASED SOLUTIONS 93
  • 9.4.2 WEB SOLUTIONS 93
  • 9.4.3 HANDHELD 93
• 9.5 HOSPITALS/HEALTHCARE PROVIDERS 93
  • 9.5.1 SITE-BASED SOLUTIONS 94
  • 9.5.2 WEB SOLUTIONS 94
  • 9.5.3 HANDHELD 94
• 9.6 CONSULTING SERVICE COMPANIES 94
  • 9.6.1 SITE-BASED SOLUTIONS 95
  • 9.6.2 WEB SOLUTIONS 95
  • 9.6.3 HANDHELD 95
• 9.7 ACADEMIC & RESEARCH INSTITUTES 95
  • 9.7.1 SITE-BASED SOLUTIONS 96
  • 9.7.2 WEB SOLUTIONS 96
  • 9.7.3 HANDHELD 96
• 9.8 OTHERS 96
  • 9.8.1 SITE-BASED SOLUTIONS 97
  • 9.8.2 WEB SOLUTIONS 97
  • 9.8.3 HANDHELD 97

10 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 98

• 10.1 OVERVIEW 99
• 10.2 CLOUD-BASED 100
• 10.3 WEB-HOSTED 100

11 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION 101

• 11.1 EUROPE 103
  • 11.1.1 GERMANY 108
  • 11.1.2 U.K. 112
  • 11.1.3 FRANCE 116
  • 11.1.4 ITALY 120
  • 11.1.5 RUSSIA 124
  • 11.1.6 SPAIN 128
  • 11.1.7 POLAND 132
  • 11.1.8 TURKEY 136
  • 11.1.9 NETHERLANDS 140
  • 11.1.10 BELGIUM 144
  • 11.1.11 SWITZERLAND 148
  • 11.1.12 SWEDEN 152
  • 11.1.13 DENMARK 156
  • 11.1.14 FINLAND 160
  • 11.1.15 NORWAY 164
  • 11.1.16 REST OF EUROPE 168

12 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: COMPANY LANDSCAPE 169

• 12.1 COMPANY SHARE ANALYSIS: EUROPE 169

13 SWOT ANALYSIS 170

14 COMPANY PROFILE 171

• 14.1 MEDIDATA 171
  • 14.1.1 COMPANY SNAPSHOT 171
  • 14.1.2 REVENUE ANALYSIS 171
  • 14.1.3 COMPANY SHARE ANALYSIS 172
  • 14.1.4 SOLUTION PORTFOLIO 172
  • 14.1.5 RECENT DEVELOPMENTS 172
• 14.2 IQVIA INC 175
  • 14.2.1 COMPANY SNAPSHOT 175
  • 14.2.2 REVENUE ANALYSIS 175
  • 14.2.3 COMPANY SHARE ANALYSIS 176
  • 14.2.4 PRODUCT PORTFOLIO 176
  • 14.2.5 RECENT DEVELOPMENTS 176
• 14.3 CLARIO 178
  • 14.3.1 COMPANY SNAPSHOT 178
  • 14.3.2 COMPANY SHARE ANALYSIS 178
  • 14.3.3 SOLUTION PORTFOLIO 179
  • 14.3.4 RECENT DEVELOPMENTS 179
• 14.4 SIGNANT HEALTH 181
  • 14.4.1 COMPANY SNAPSHOT 181
  • 14.4.2 SOLUTION PORTFOLIO 181
  • 14.4.3 RECENT DEVELOPMENTS 182
• 14.5 ARISEUROPE 183
  • 14.5.1 COMPANY SNAPSHOT 183
  • 14.5.2 SOLUTION PORTFOLIO 183
  • 14.5.3 RECENT DEVELOPMENTS 185
• 14.6 ASSISTEK 187
  • 14.6.1 COMPANY SNAPSHOT 187
  • 14.6.2 SERVICE PORTFOLIO 187
  • 14.6.3 RECENT DEVELOPMENT 188

• 14.7 CASTOR 189
  • 14.7.1 COMPANY SNAPSHOT 189
  • 14.7.2 PRODUCT PORTFOLIO 189
  • 14.7.3 RECENT DEVELOPMENTS 190
• 14.8 CLIMEDO HEALTH GMBH 191
  • 14.8.1 COMPANY SNAPSHOT 191
  • 14.8.2 PRODUCT PORTFOLIO 191
  • 14.8.3 RECENT DEVELOPMENT 191
• 14.9 CLINCAPTURE 192
  • 14.9.1 COMPANY SNAPSHOT 192
  • 14.9.2 PRODUCT PORTFOLIO 192
  • 14.9.3 RECENT DEVELOPMENT 192
• 14.10 CLINICAL INK 193
  • 14.10.1 COMPANY SNAPSHOT 193
  • 14.10.2 SOLUTION PORTFOLIO 193
  • 14.10.3 RECENT DEVELOPMENTS 194
• 14.11 CLOUDBYZ 195
  • 14.11.1 COMPANY SNAPSHOT 195
  • 14.11.2 SOLUTION PORTFOLIO 195
  • 14.11.3 RECENT DEVELOPMENTS 195
• 14.12 CRUCIAL DATA SOLUTIONS 197
  • 14.12.1 COMPANY SNAPSHOT 197
  • 14.12.2 SOLUTION PORTFOLIO 197
  • 14.12.3 RECENT DEVELOPMENTS 197
• 14.13 EVIDENTIQ 199
  • 14.13.1 COMPANY SNAPSHOT 199
  • 14.13.2 PRODUCT PORTFOLIO 199
  • 14.13.3 RECENT DEVELOPMENTS 200
• 14.14 KAYENTIS 201
  • 14.14.1 COMPANY SNAPSHOT 201
  • 14.14.2 SOLUTION PORTFOLIO 201
  • 14.14.3 RECENT DEVELOPMENTS 201
• 14.15 MEDABLE INC. 203
  • 14.15.1 COMPANY SNAPSHOT 203
  • 14.15.2 PRODUCT PORTFOLIO 203
  • 14.15.3 RECENT DEVELOPMENTS 204
• 14.16 MERATIVE 205
  • 14.16.1 COMPANY SNAPSHOT 205
  • 14.16.2 SOLUTION PORTFOLIO 205
  • 14.16.3 RECENT DEVELOPMENTS 205
• 14.17 PATTERN HEALTH TECHNOLOGIES, INC. 207
  • 14.17.1 COMPANY SNAPSHOT 207
  • 14.17.2 SERVICE PORTFOLIO 207
  • 14.17.3 RECENT DEVELOPMENTS 207
• 14.18 RAYLYTIC GMBH 209
  • 14.18.1 COMPANY SNAPSHOT 209
  • 14.18.2 SOLUTION PORTFOLIO 209
  • 14.18.3 RECENT DEVELOPMENT 210
• 14.19 SUVODA LLC 211
  • 14.19.1 COMPANY SNAPSHOT 211
  • 14.19.2 PRODUCT PORTFOLIO 211
  • 14.19.3 RECENT DEVELOPMENT 212
• 14.20 TRANSPERFECT LIFE SCIENCES 213
  • 14.20.1 COMPANY SNAPSHOT 213
  • 14.20.2 SOLUTION PORTFOLIO 213
  • 14.20.3 RECENT DEVELOPMENT 214
• 14.21 VITALOGRAPH 215
  • 14.21.1 COMPANY SNAPSHOT 215
  • 14.21.2 SERVICES PORTFOLIO 215
  • 14.21.3 RECENT DEVELOPMENTS 216
• 14.22 WCG CLINICAL 217
  • 14.22.1 COMPANY SNAPSHOT 217
  • 14.22.2 PRODUCT PORTFOLIO 217
  • 14.22.3 RECENT DEVELOPMENT 217
• 14.23 YPRIME LLC. 219
  • 14.23.1 COMPANY SNAPSHOT 219
  • 14.23.2 SOLUTION PORTFOLIO 219
  • 14.23.3 RECENT DEVELOPMENTS 220

15 QUESTIONNAIRE 222

16 RELATED REPORTS 225

LIST OF TABLES

• TABLE 1 COST COMPARISON - PAPER COA TO ECOA 52
• TABLE 2 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 60
• TABLE 3 EUROPE CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 60
• TABLE 4 EUROPE PATIENT REPORTED OUTCOME ASSESSMENT (PRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
• TABLE 5 EUROPE OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
• TABLE 6 EUROPE PERFORMANCE OUTCOME ASSESSMENT (PERFO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 62
• TABLE 7 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 65
• TABLE 8 EUROPE SITE-BASED SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 65
• TABLE 9 EUROPE WEB SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
• TABLE 10 EUROPE HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
• TABLE 11 EUROPE HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 67
• TABLE 12 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 70
• TABLE 13 EUROPE CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 70
• TABLE 14 EUROPE CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 71
• TABLE 15 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 71
• TABLE 16 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 72
• TABLE 17 EUROPE MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 72
• TABLE 18 EUROPE MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 73
• TABLE 19 EUROPE HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 73
• TABLE 20 EUROPE HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 74
• TABLE 21 EUROPE CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 74
• TABLE 22 EUROPE CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 75
• TABLE 23 EUROPE ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 75
• TABLE 24 EUROPE ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 76
• TABLE 25 EUROPE OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 76
• TABLE 26 EUROPE OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 77
• TABLE 27 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE, 2022-2031 (USD THOUSAND) 80
• TABLE 28 EUROPE CLOUD-BASED IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 80
• TABLE 29 EUROPE WEB-HOSTED IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 80
• TABLE 30 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION, 2022-2031 (USD THOUSAND) 83
• TABLE 31 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 84
• TABLE 32 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 84
• TABLE 33 EUROPE HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 84
• TABLE 34 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 85
• TABLE 35 EUROPE CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 85
• TABLE 36 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 85
• TABLE 37 EUROPE MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 86
• TABLE 38 EUROPE HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 86
• TABLE 39 EUROPE CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 86
• TABLE 40 EUROPE ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 86
• TABLE 41 EUROPE OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 87
• TABLE 42 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 87
• TABLE 43 GERMANY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 88
• TABLE 44 GERMANY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 88
• TABLE 45 GERMANY HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 88
• TABLE 46 GERMANY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 89
• TABLE 47 GERMANY CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 89
• TABLE 48 GERMANY PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 89
• TABLE 49 GERMANY MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 90
• TABLE 50 GERMANY HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 90
• TABLE 51 GERMANY CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 90
• TABLE 52 GERMANY ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 90
• TABLE 53 GERMANY OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 91
• TABLE 54 GERMANY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 91
• TABLE 55 U.K. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 92
• TABLE 56 U.K. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 92
• TABLE 57 U.K. HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 92
• TABLE 58 U.K. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 93
• TABLE 59 U.K. CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 93
• TABLE 60 U.K. PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 93
• TABLE 61 U.K. MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 94
• TABLE 62 U.K. HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 94
• TABLE 63 U.K. CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 94
• TABLE 64 U.K. ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 95
• TABLE 65 U.K. OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 95
• TABLE 66 U.K. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 95
• TABLE 67 FRANCE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 96
• TABLE 68 FRANCE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 96
• TABLE 69 FRANCE HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 96
• TABLE 70 FRANCE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 97
• TABLE 71 FRANCE CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 97
• TABLE 72 FRANCE PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 97
• TABLE 73 FRANCE MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 98
• TABLE 74 FRANCE HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 98
• TABLE 75 FRANCE CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 98
• TABLE 76 FRANCE ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 98
• TABLE 77 FRANCE OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 99
• TABLE 78 FRANCE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 99
• TABLE 79 ITALY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 100
• TABLE 80 ITALY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 100
• TABLE 81 ITALY HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 100
• TABLE 82 ITALY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 101
• TABLE 83 ITALY CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 101
• TABLE 84 ITALY PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 101
• TABLE 85 ITALY MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 102
• TABLE 86 ITALY HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 102
• TABLE 87 ITALY CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 102
• TABLE 88 ITALY ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 102
• TABLE 89 ITALY OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 103
• TABLE 90 ITALY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 103
• TABLE 91 RUSSIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 104
• TABLE 92 RUSSIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 104
• TABLE 93 RUSSIA HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 104
• TABLE 94 RUSSIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 105
• TABLE 95 RUSSIA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 105
• TABLE 96 RUSSIA PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 105
• TABLE 97 RUSSIA MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 106
• TABLE 98 RUSSIA HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 106
• TABLE 99 RUSSIA CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 106
• TABLE 100 RUSSIA ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 106
• TABLE 101 RUSSIA OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 107
• TABLE 102 RUSSIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 107
• TABLE 103 SPAIN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 108
• TABLE 104 SPAIN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 108
• TABLE 105 SPAIN HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 108
• TABLE 106 SPAIN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 109
• TABLE 107 SPAIN CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 109
• TABLE 108 SPAIN PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 109
• TABLE 109 SPAIN MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 110
• TABLE 110 SPAIN HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 110
• TABLE 111 SPAIN CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 110
• TABLE 112 SPAIN ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 110
• TABLE 113 SPAIN OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 111
• TABLE 114 SPAIN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 111
• TABLE 115 POLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 112
• TABLE 116 POLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 112
• TABLE 117 POLAND HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 112
• TABLE 118 POLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 113
• TABLE 119 POLAND CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 113
• TABLE 120 POLAND PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 113
• TABLE 121 POLAND MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 114
• TABLE 122 POLAND HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 114
• TABLE 123 POLAND CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 114
• TABLE 124 POLAND ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 114
• TABLE 125 POLAND OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 115
• TABLE 126 POLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 115
• TABLE 127 TURKEY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 116
• TABLE 128 TURKEY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 116
• TABLE 129 TURKEY HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 116
• TABLE 130 TURKEY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 117
• TABLE 131 TURKEY CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 117
• TABLE 132 TURKEY PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 117
• TABLE 133 TURKEY MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 118
• TABLE 134 TURKEY HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 118
• TABLE 135 TURKEY CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 118
• TABLE 136 TURKEY ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 118
• TABLE 137 TURKEY OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 119
• TABLE 138 TURKEY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 119
• TABLE 139 NETHERLANDS ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 120
• TABLE 140 NETHERLANDS ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 120
• TABLE 141 NETHERLANDS HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 120
• TABLE 142 NETHERLANDS ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 121
• TABLE 143 NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 121
• TABLE 144 NETHERLANDS PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 121
• TABLE 145 NETHERLANDS MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 122
• TABLE 146 NETHERLANDS HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 122
• TABLE 147 NETHERLANDS CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 122
• TABLE 148 NETHERLANDS ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 122
• TABLE 149 NETHERLANDS OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 123
• TABLE 150 NETHERLANDS ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 123
• TABLE 151 BELGIUM ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 124
• TABLE 152 BELGIUM ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 124
• TABLE 153 BELGIUM HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 124
• TABLE 154 BELGIUM ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 125
• TABLE 155 BELGIUM CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 125
• TABLE 156 BELGIUM PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 125
• TABLE 157 BELGIUM MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 126
• TABLE 158 BELGIUM HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 126
• TABLE 159 BELGIUM CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 126
• TABLE 160 BELGIUM ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 126
• TABLE 161 BELGIUM OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 127
• TABLE 162 BELGIUM ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 127
• TABLE 163 SWITZERLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 128
• TABLE 164 SWITZERLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 128
• TABLE 165 SWITZERLAND HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 128
• TABLE 166 SWITZERLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 129
• TABLE 167 SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 129
• TABLE 168 SWITZERLAND PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 129
• TABLE 169 SWITZERLAND MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 130
• TABLE 170 SWITZERLAND HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 130
• TABLE 171 SWITZERLAND CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 130
• TABLE 172 SWITZERLAND ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 130
• TABLE 173 SWITZERLAND OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 131
• TABLE 174 SWITZERLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 131
• TABLE 175 SWEDEN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 132
• TABLE 176 SWEDEN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 132
• TABLE 177 SWEDEN HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 132
• TABLE 178 SWEDEN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 133
• TABLE 179 SWEDEN CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 133
• TABLE 180 SWEDEN PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 133
• TABLE 181 SWEDEN MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 134
• TABLE 182 SWEDEN HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 134
• TABLE 183 SWEDEN CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 134
• TABLE 184 SWEDEN ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 134
• TABLE 185 SWEDEN OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 135
• TABLE 186 SWEDEN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 135
• TABLE 187 DENMARK ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 136
• TABLE 188 DENMARK ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 136
• TABLE 189 DENMARK HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 136
• TABLE 190 DENMARK ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 137
• TABLE 191 DENMARK CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 137
• TABLE 192 DENMARK PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 137
• TABLE 193 DENMARK MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 138
• TABLE 194 DENMARK HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 138
• TABLE 195 DENMARK CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 138
• TABLE 196 DENMARK ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 138
• TABLE 197 DENMARK OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 139
• TABLE 198 DENMARK ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 139
• TABLE 199 FINLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 140
• TABLE 200 FINLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 140
• TABLE 201 FINLAND HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 140
• TABLE 202 FINLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 141
• TABLE 203 FINLAND CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 141
• TABLE 204 FINLAND PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 141
• TABLE 205 FINLAND MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 142
• TABLE 206 FINLAND HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 142
• TABLE 207 FINLAND CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 142
• TABLE 208 FINLAND ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 142
• TABLE 209 FINLAND OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 143
• TABLE 210 FINLAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 143
• TABLE 211 NORWAY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 144
• TABLE 212 NORWAY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 144
• TABLE 213 NORWAY HANDHELD IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 144
• TABLE 214 NORWAY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2022-2031 (USD THOUSAND) 145
• TABLE 215 NORWAY CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 145
• TABLE 216 NORWAY PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 145
• TABLE 217 NORWAY MEDICAL DEVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 146
• TABLE 218 NORWAY HOSPITALS/HEALTHCARE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 146
• TABLE 219 NORWAY CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 146
• TABLE 220 NORWAY ACADEMIC & RESEARCH INSTITUTES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 146
• TABLE 221 NORWAY OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 147
• TABLE 222 NORWAY ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 2022-2031 (USD THOUSAND) 147
• TABLE 223 REST OF EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 148

LIST OF FIGURES

• FIGURE 1 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: SEGMENTATION 27
• FIGURE 2 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: DATA TRIANGULATION 30
• FIGURE 3 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: DROC ANALYSIS 31
• FIGURE 4 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 32
• FIGURE 5 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: COMPANY RESEARCH ANALYSIS 32
• FIGURE 6 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: INTERVIEW DEMOGRAPHICS 33
• FIGURE 7 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: DBMR MARKET POSITION GRID 34
• FIGURE 8 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: VENDOR SHARE ANALYSIS 36
• FIGURE 9 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: MULTIVARIATE MODELLING 37
• FIGURE 10 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: TYPE TIMELINE CURVE 38
• FIGURE 11 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: MARKET APPLICATION COVERAGE GRID 39
• FIGURE 12 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: SEGMENTATION 42
• FIGURE 13 GROWING ACCEPTANCE OF ECOA AMONG CLINICAL RESEARCH PROFESSIONALS IS DRIVING THE GROWTH OF THE EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031 43
• FIGURE 14 THE CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET IN 2024 AND 2031 43
• FIGURE 15 PESTEL ANALYSIS: EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 44
• FIGURE 16 PORTER'S FIVE FORCES ANALYSIS: EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 45
• FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 49
• FIGURE 18 ADOPTION OF APPLICATIONS TO MANAGE CLINICAL STUDIES 51
• FIGURE 19 CLOUD SHIFT PROPORTION, BY CATEGORY 55
• FIGURE 20 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: BY TYPE, 2023 59
• FIGURE 21 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: BY MODALITY, 2023 64
• FIGURE 22 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: BY END USER, 2023 69
• FIGURE 23 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: BY DELIVERY MODE, 2023 79
• FIGURE 24 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: SNAPSHOT (2023) 82
• FIGURE 25 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: COMPANY SHARE 2023 (%) 149